NAN Stock Overview
Operates as an infection prevention company globally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Nanosonics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$3.00 |
| 52 Week High | AU$4.45 |
| 52 Week Low | AU$2.59 |
| Beta | 1.57 |
| 1 Month Change | -7.98% |
| 3 Month Change | -15.61% |
| 1 Year Change | -30.88% |
| 3 Year Change | -49.66% |
| 5 Year Change | -54.20% |
| Change since IPO | 277.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| NAN | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -2.3% | -0.7% | -0.09% |
| 1Y | -30.9% | 1.5% | 8.3% |
Return vs Industry: NAN underperformed the Australian Medical Equipment industry which returned 0.2% over the past year.
Return vs Market: NAN underperformed the Australian Market which returned 7.4% over the past year.
Price Volatility
| NAN volatility | |
|---|---|
| NAN Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in AU Market | 16.7% |
| 10% least volatile stocks in AU Market | 3.0% |
Stable Share Price: NAN has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: NAN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 466 | Michael Kavanagh | www.nanosonics.com.au |
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.
Nanosonics Limited Fundamentals Summary
| NAN fundamental statistics | |
|---|---|
| Market cap | AU$913.68m |
| Earnings (TTM) | AU$12.97m |
| Revenue (TTM) | AU$170.01m |
70.4x
P/E Ratio5.4x
P/S RatioIs NAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NAN income statement (TTM) | |
|---|---|
| Revenue | AU$170.01m |
| Cost of Revenue | AU$37.58m |
| Gross Profit | AU$132.44m |
| Other Expenses | AU$119.47m |
| Earnings | AU$12.97m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.043 |
| Gross Margin | 77.90% |
| Net Profit Margin | 7.63% |
| Debt/Equity Ratio | 0% |
How did NAN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 13:30 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nanosonics Limited is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Josh Kannourakis | Barrenjoey Markets Pty Limited |
| John Hester | Bell Potter |